LQDA FY 2021 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena

LQDALiquidia Corporation

$3B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$13M+1637.8% YoY

Gross Profit

$10M76.5% margin

Operating Income

-$34M-263.0% margin

Net Income

-$35M-269.0% margin

EPS (Diluted)

$-0.70

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$34M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$94M

Total Liabilities

$28M

Stockholders' Equity

$65M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$739,628	+1637.8%
Gross Profit	$10M	$501,916	+1858.5%
Operating Income	-$34M	-$59M	+42.8%
Net Income	-$35M	-$60M	+42.1%